Dr. Reddy's Laboratories
169 hedge funds and large institutions have $1.15B invested in Dr. Reddy's Laboratories in 2020 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 42 increasing their positions, 65 reducing their positions, and 12 closing their positions.
167% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 12
34% more call options, than puts
Call options by funds: $1.48M | Put options by funds: $1.1M
33% more capital invested
Capital invested by funds: $862M → $1.15B (+$284M)
13% more funds holding
Funds holding: 149 → 169 (+20)
0.84% more ownership
Funds ownership: 64.24% → 65.08% (+0.84%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
35% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 65
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$18.2M |
| 2 |
Morgan Stanley
New York
|
+$11.9M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$11.9M |
| 4 |
Goldman Sachs
New York
|
+$11.6M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$10.1M |
Top Sellers
| 1 |
BlackRock
New York
|
-$9.29M |
| 2 |
N
Natixis
Paris,
France
|
-$8.75M |
| 3 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$7.56M |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$7.29M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$7.29M |
RDY Hedge Fund Activity: Q2 2020 in Review
169 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q2 2020, worth a combined $1.15B — up 33% from $862M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new RDY positions and 12 closed out — a net gain of 20 holders — while 42 added to existing stakes and 65 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $18.2M. The largest seller was BlackRock, cutting an estimated $9.29M.
- 169 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q2 2020, up from 149 in Q1 2020.
- Funds reported $1.15B of Dr. Reddy's Laboratories stock for Q2 2020, up 33% quarter-over-quarter.
- 32 funds opened new Dr. Reddy's Laboratories positions in Q2 2020 and 12 closed out, a net change of +20 holders.
- The largest Dr. Reddy's Laboratories buyer in Q2 2020 was Renaissance Technologies, an estimated $18.2M added.
- The largest Dr. Reddy's Laboratories seller in Q2 2020 was BlackRock, an estimated $9.29M sold.
Based on aggregated 13F filings for Q2 2020.